Serum from patients with severe heart failure downregulates eNOS and is proapoptotic. Role of tumor necrosis factor-α

Circulation

Volumn 100, Issue 19, 1999, Pages 1983-1991

  Agnoletti, Laura ^a   Curello, Salvatore ^a   Bachetti, Tiziana ^a   Malacarne, Fabio ^b   Gaia, Giuseppina ^a   Comini, Laura ^a   Volterrani, Maurizio ^c   Bonetti, Paolo ^a   Parrinello, Giovanni ^a   Cadei, Moris ^a   Grigolato, Pier Giovanni ^a   Ferrari, Roberto ^d,e  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Immunology Department   (Italy)

^c Cardiology Department   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e IRCCS   (Italy)

Author keywords

Apoptosis; Endothelium; Heart failure; Nitric oxide synthase; Tumor necrosis factor

Indexed keywords

LIPOCORTIN 5; NITRIC OXIDE SYNTHASE; PROPIDIUM IODIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; APOPTOSIS; ARTICLE; CONGESTIVE HEART FAILURE; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTHELIUM; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033539585     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.19.1983     Document Type: Article

References (33)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
2. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest. 1994;105: 897-904.
3. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;92:1479-1486.
4. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92: 1479-1486.
5. Shan K, Kurrelmeyer K, Seta Y, Wang F, Dibbs Z, Deswal A, Lee-Jackson D, Mann DL. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol. 1997;12:218-223.
6. Oral H, Kapadia S, Nakano M, Torre-Amione G, Lee J, Lee-Jackson D, Young JB, Mann DL. Tumor necrosis factor-alpha and the failing human heart. Clin Cardiol. 1995;18:IV20-IV27.
7. Yoshizumi M, Perrella MA, Burnett JC, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73:205-209.
8. Smith CG, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu X-B, Kobary Y, Pritchard K Jr, Sessa WC, Hintze TH. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res. 1996;78:58-64.
9. Katz SD. Mechanisms and implications of endothelial dysfunction in congestive heart failure. Curr Opin Cardiol. 1997;12:259-264.
10. Packer M. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation. 1995;92:1379-1382.
11. Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou R, LeJemtel TH. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation. 1994;90:12-16.
12. Ceconi C, Condorelli E, Quinzanini M, Rodella A, Ferrari R, Harris P. Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. Cardiovasc Res. 1989;23:674-682.
13. Jaffe EA, Nachman L, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973;52: 2745-2756.
14. Bachetti T, Comini L, Agnoletti L, Pedersini P, Gaia G, Cargnoni A, Bellet M, Curello S, Ferrari R. Effects of chronic noradrenaline on the nitric oxide pathway in human endothelial cells. Basic Res Cardiol. 1998;93:250-256.
15. Sharov VG, Sabbah HN, Shymoyama H, Goussev A, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol. 1996;148:141-149.
16. Bancroft JD, Stevens A, eds. Theory and Practice of Histological Techniques. Edinburgh: Churchill Livingstone; 1990:109-118.
17. Schulte E, Wittekind D. Standardization of Feulgen-Schiff technique. Histochemistry. 1989;91:321-333.
18. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139: 271-279.
19. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J Immunol Methods. 1995;184:39-51.
20. Ryan US, Rubanyi GM, eds. Endothelial Regulation of Vascular Tone. New York: Marcel Dekker Inc; 1992.
21. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in umbilical vein endothelial cells. J Clin Invest 1994;93: 2236-2243.
22. Hornig B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation. 1997;95:1115-1118.
23. Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998;97: 1129-1135.
24. Sen S. Programmed cell death: concept, mechanism and control. Biol Rev. 1992;67:287-319.
25. MacLellan WR, Schneider MD. Death by design: programmed cell death in cardiovascular biology and disease. Circ Res. 1997;81:137-144.
26. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest. 1994;71:219-225.
27. Kroemer G, Petit P, Zamzami N, Vayssière JL, Mignotte B. The biochemistry of programmed cell death. FASEB J. 1995;9:1277-1287.
28. Nagata S. Apoptosis by death factor. Cell. 1997;88:355-365.
29. Osborne BA, Schwartz LM. Essential genes that regulate apoptosis. Trends Cell Biol. 1994;4:394-403.
30. Schultze-Osthoff K, Krammer PH, Droge W. Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 1994;13:4587-4596.
31. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13:151-153.
32. Tan X, Wang YJ. The caspase-RB connection in cell death. Trends Cell Biol. 1998;8:116-120.
33. Linscheid P, Schaffner A, Blau N, Schoedon G. Regulation of 6-pyruvoyltetrahydropterin synthase activity and messenger RNA abundance in human vascular endothelial cells. Circulation 1998;98: 1703-1706.